HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Boots first half

This article was originally published in The Rose Sheet

Executive Summary

Boots Healthcare International sales rose 7.6% in the first half, British company reports Sept. 29. In addition, "The proposed disposal of BHI is on track," firm notes. Boots announced it would divest its OTC consumer business in April (1"The Rose Sheet" April 11, 2005, p. 9). Boots the Chemists net sales were up 1.1%, but declined 1.3% on a like-for-like basis...

You may also be interested in...



Boots To Unload OTC Business, Citing Market Consolidation

Merger and acquisition activity in the OTC drug industry has prompted Boots the Chemists to put its healthcare unit up for sale

Data For Two HER2-Positive Breast Cancer Drugs Impress, Including On Overall Survival

AstraZeneca/Daiichi Sankyo and Seattle Genetics presented exciting data at SABCS on drugs that extended survival in patients who had exhausted most treatment options.

The FDA Builds On Lessons Learned In Rebuilding Quality Metrics Program

US FDA officials tell industry that implementing a quality metrics program is an agency priority and that a rejiggered program will incorporate various elements of other quality metrics initiatives being piloted by the agency, industry and academia.

UsernamePublicRestriction

Register

RS013390

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel